DE2700085A1 - Arzneimittel - Google Patents

Arzneimittel

Info

Publication number
DE2700085A1
DE2700085A1 DE19772700085 DE2700085A DE2700085A1 DE 2700085 A1 DE2700085 A1 DE 2700085A1 DE 19772700085 DE19772700085 DE 19772700085 DE 2700085 A DE2700085 A DE 2700085A DE 2700085 A1 DE2700085 A1 DE 2700085A1
Authority
DE
Germany
Prior art keywords
medicament according
active ingredients
gelatin capsules
chenodeoxycholic acid
hymecromone
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE19772700085
Other languages
German (de)
English (en)
Inventor
Jean-Claude Lechevin
Jean-Noel Treilles
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Sante SAS
Original Assignee
LIPHA SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LIPHA SAS filed Critical LIPHA SAS
Publication of DE2700085A1 publication Critical patent/DE2700085A1/de
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
DE19772700085 1976-07-13 1977-01-04 Arzneimittel Withdrawn DE2700085A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7621376A FR2358144A1 (fr) 1976-07-13 1976-07-13 Nouvelle composition medicamenteuse pour le traitement de la lithiase biliaire

Publications (1)

Publication Number Publication Date
DE2700085A1 true DE2700085A1 (de) 1978-01-26

Family

ID=9175646

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19772700085 Withdrawn DE2700085A1 (de) 1976-07-13 1977-01-04 Arzneimittel

Country Status (4)

Country Link
BE (1) BE856740A (fr)
DE (1) DE2700085A1 (fr)
FR (1) FR2358144A1 (fr)
ZA (1) ZA774164B (fr)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0240874A1 (fr) * 1986-04-05 1987-10-14 Dolorgiet GmbH & Co. KG Préparation de l'hymécromone à résorption élevée et son procédé de préparation
AT392904B (de) * 1984-03-19 1991-07-10 Bristol Myers Squibb Co Verfahren zur herstellung einer zur oralen verabreichung von etoposid bestimmten weichgelantinekapsel
AT392906B (de) * 1987-10-08 1991-07-10 Hoffmann La Roche Pharmazeutische praeparate zur oralen verabreichung

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1101649B (it) * 1978-12-15 1985-10-07 Lehner Ag Composizione farmaceutica ad azione prolungata contenente acidi biliari
IT1136624B (it) * 1981-05-21 1986-09-03 Erregierre Ind Chim Spa Prodotti di salificazione di acidi colici,processo per la loro preparazione e composizioni terapeutiche che li comprendono come principio attivo
IT1245890B (it) * 1991-04-12 1994-10-25 Alfa Wassermann Spa Formulazioni farmaceutiche per uso orale gastroresistenti contenenti acidi biliari.
IT1245889B (it) * 1991-04-12 1994-10-25 Alfa Wassermann Spa Formulazioni farmaceutiche per uso orale gastroresistenti contenenti sali di acidi biliari.
GB9308469D0 (en) * 1993-04-23 1993-06-09 Wright George H Management of cholelithiasis

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT392904B (de) * 1984-03-19 1991-07-10 Bristol Myers Squibb Co Verfahren zur herstellung einer zur oralen verabreichung von etoposid bestimmten weichgelantinekapsel
EP0240874A1 (fr) * 1986-04-05 1987-10-14 Dolorgiet GmbH & Co. KG Préparation de l'hymécromone à résorption élevée et son procédé de préparation
AT392906B (de) * 1987-10-08 1991-07-10 Hoffmann La Roche Pharmazeutische praeparate zur oralen verabreichung

Also Published As

Publication number Publication date
FR2358144B1 (fr) 1978-12-15
FR2358144A1 (fr) 1978-02-10
BE856740A (fr) 1978-01-12
ZA774164B (en) 1978-05-30

Similar Documents

Publication Publication Date Title
EP0068191B1 (fr) Formes orales du dipyridamole
DE3100808C2 (fr)
DE69011766T2 (de) Wässerige Arzneisuspension für im wesentlichen wasserunlösliche Arzneiwirkstoffe.
DE69000881T2 (de) 2-propylvaleriansaeure enthaltende arzneizubereitung mit verzoegerter wirkstofffreigabe.
DE69230112T2 (de) Fortschrittliches arzneistoffabgabesystem und verfahren zur behandlung von psychiatrischen, neurologischen und anderen erkrankungen mit carbamazepin
DE69830728T2 (de) Arzneimittel zur behandlung von häufigem wasserlassen und harninkontinenz
DE60026459T2 (de) Simethicon enthaltendes Abführmittel
DE3887826T2 (de) Nifedipin enthaltende Kapsel zur sofortigen oralen Freisetzung.
DE69429632T2 (de) Dosisform mit gesteuerter freigabe für kalium
DE19529862A1 (de) Pharmazeutische, oral anwendbare Zubereitung
DE69128760T2 (de) Antidiarrhoeika
EP0125634A1 (fr) Utilisation d'une substance sécrétolytique pour l'obtention d'un agent contre le ronflement et pour combattre le phénomène de ronflement
EP0339420A2 (fr) Préparation à base de DHP à libération retardée
DE4140192A1 (de) Sol-gesteuerte thermokolloidmatrix auf gelatinebasis fuer perorale retardformen
DE3343934A1 (de) M-chlor-(alpha)-tert.-butylaminopropiophenon und seine verwendung zur senkung des cholesterolspiegels
EP0471967A1 (fr) Comprimé à mâcher à base de sucralfate
DE2700085A1 (de) Arzneimittel
DD238920A5 (de) Verfahren zur herstellung einer verbesserten entzuendungshemmend wirkenden zusammensetzung
DE2529148C2 (de) Pharmazeutisches Pulver zur Herstellung einer schmackhaften oralen Dosisform eines blutbildenden Mittels
DE3338978A1 (de) Verapamil und gallopamil und ihre physiologisch vertraeglichen salze zur resorptiven anwendung auf den schleimhaeuten des mundes, des nasen-rachen-raums und des rektums
DE69804169T2 (de) Oral anzuwendende flüssige Arzneilösung
EP1001756B1 (fr) Compositions a effet synergique pour lutter selectivement contre les tissus tumoraux
DE69201077T2 (de) Alginsäure enthaltende Arzneisuspension.
DE2062715B2 (de) Verfahren zur herstellung von oral applizierbaren arzneimittelzubereitungen mit protrahierter wirkstoffabgabe und arzneimittelzubereitung
DE3040042A1 (de) Pharmazeutische zubereitung des tiaramids oder seiner pharmazeutisch vertraeglichen salze

Legal Events

Date Code Title Description
8141 Disposal/no request for examination